The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of ...

This week, J&J JNJ filed for voluntary bankruptcy for the third time in an attempt to bring an end to thousands of lawsuits ...

UBS has recently reduced Royalty Pharma plc (RPRX) stock to Neutral rating, as announced on June 3, 2024, according to Finviz. Earlier, on June 14, 2022, UBS had resumed the stock to Buy, setting a ...

PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia. The Boston, Massachusetts-based biotechnology company said the milestone ...

This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

Biotech companies could gain the financial flexibility to accelerate their innovations with the Fed’s recent rate cut. To ...

On Tuesday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.71 which represents no change from the prior close of $27.71. The stock opened at $27.71 and touched a low of $27 ...

Year-on-year, our royalty and silicon revenues are down almost $90 million. Over 2023, we also recorded approximately $60 million of revenue associated with the subscription license agreement with ...

Check the time stamp on this data. Updated AI-Generated Signals for Royalty Pharma Plc (RPRX) available here: RPRX.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With U.S. stock markets set to open in two hours, United States Steel Corp. (X) was up 3.5% in pre-market trading, and Royalty Pharma PLC (RPRX) was up 2.9%.